--- canonical_url: https://www.stockexpertai.com/earnings/vlto last_updated: 2026-05-09T13:52:36.947Z --- # Veralto Corporation (VLTO) Q4 FY2026 Earnings Preview > This content was automatically generated with FMP live data + Q1 FY2026 earnings call transcript. Generated: 2026-05-09T13:52:36.490Z. Educational tool, not investment advice. --- ## Quick Summary | Field | Value | Source | |---|---|---| | Price | $86.84 (▼ -2.13%) | fmp:quote | | Market Cap | $21.3B | fmp:profile | | 52w range | $84.99 – $110.11 | fmp:quote | | Earnings | Thu 23 Jul | fmp:earnings-history | | EPS estimate | $1.00 (+8% YoY) | fmp:earnings-estimate | | Revenue estimate | $1.5B | fmp:earnings-estimate | | Beat streak | 8/4 | fmp:earnings-history | | Rating | B+ (overall 3/5) | fmp:ratings | | Analyst median target | $105 (+20.9% upside) | fmp:price-target-consensus | | MoonshotScore | 47/100 | derived | | Council | 2/6 bullish | derived | | Munger verdict | Fairly Valued | derived | ## Veralto Corporation — Q4 FY2026 Expectations Q4 consensus: revenue $1.5B^{[FMP est]}, EPS $1.00^{[FMP est]}. 8 consecutive quarters of beat^{[FMP earnings]}. ## Quick Take **Score:** B+ · **Stance:** BUY · **Council:** 2/6 · **Moonshot:** 47 = MoonshotScore 47^{[9-pillar formula]} + Council 2/6^{[6-lens rule]}. Form 4: 0 transactions^{[FMP Form 4]}. ## Watchlist (6 metrics) ### 1. Fy26 Eps Guidance Veralto raised its full year adjusted earnings per share guidance to a range of $4.20 to $4.28 per share, reflecting its strong first quarter and momentum throughout the year. > "Reflecting this momentum and our strong first quarter, we raised our full year adjusted earnings per share guidance to a range of $4.20 to $4.28 per share." > — Jennifer Honeycutt, CEO, Expectation / Guide · Q1 FY2026 ### 2. Strategic Acquisitions Veralto invested approximately $1 billion across 2 strategic acquisitions: In-Situ in our Water Quality segment and GlobalVision in our PQI segment, and also made opportunistic share repurchases. > "Thus far this year, we have invested approximately $1 billion across 2 strategic acquisitions: In-Situ in our Water Quality segment and GlobalVision in our PQI segment, and also made opportunistic share repurchases." > — Jennifer Honeycutt, CEO, Investor Focus · Q1 FY2026 ### 3. Cost Optimization Timeline Approximately 50% of the run rate savings from Veralto's cost optimization program are expected in 2027, with the full run rate in 2028; no benefit has been baked into guidance for 2026. > "You should expect roughly 50% of the run rate savings in '27 and full run rate in 2028. That's how you can model the savings." > — Sameer Ralhan, CFO, Investor Focus · Q1 FY2026 ### 4. Water Quality Demand Veralto sees strong and stable demand across both its muni and industrial markets, with incrementally stronger growth in muni wastewater due to recycle, reclaim and reuse secular drivers. > "Yes, we see strong and stable demand across both our muni and industrial markets. To your point, the Veralto products and services really sit within customer operations where the cost of failure is high for them, right? And using our equipment is part and parcel to ensuring public safety, public health and so on." > — Jennifer Honeycutt, CEO, Investor Focus · Q1 FY2026 ### 5. Pqi Packaging Color Decline In PQI, packaging and color sales were down high single digits in Q1, primarily due to nonrecurring revenue, including sales of color testing and packaging inspection equipment, focused in a few discrete industrial end markets, such as automotive, textiles, building materials. > "When you look at Q1 here relative to packaging and color, as you noted, we do see sales down high single digits here, primarily due to the nonrecurring revenue, including sales of color testing and packaging inspection equipment. But this was really focused in a few discrete industrial end markets, so automotive, textiles, building materials, driven by housing market and so on." > — Jennifer Honeycutt, CEO, Investor Focus · Q1 FY2026 ### 6. Cost Optimization Program Veralto initiated a new cost optimization program designed to streamline our business and enhance operating efficiency. > "Additionally, we initiated a new cost optimization program designed to streamline our business and enhance operating efficiency." > — Jennifer Honeycutt, CEO, Investor Focus · Q1 FY2026 ## MoonshotScore Pillars | Pillar | Score | Level | Evidence | |---|---|---|---| | Revenue Growth | 2.0 | weak | Q1 vs Q2: moderate growth (+3.7%) | | Gross Margin | 6.0 | medium | Q1: high margin (60.1%) | | Operating Leverage | 2.0 | weak | op margin healthy (23.8%) | | Cash Runway | 10.0 | strong | FCF very strong ($0.2B, 14.2× CapEx) | | R&D Intensity | 3.0 | weak | average R&D (4.8%) | | Price Momentum | 4.0 | medium | RSI 43.1 weak momentum, 50d below | | News Sentiment | 6.0 | medium | majority buy (60%) | **Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula. ## Council (7-Lens) | Name | Stance | Context | |---|---|---| | Ray Dalio | bull | macro · target upside +20.9% | | Ken Griffin | bear | flow · 50d MA below | | Jim Simons | neutral | quant · RSI 43 | | Klarman | neutral | value · target upside +20.9% | | Buffett | bull | quality · ROE score 5/5 | | Munger | neutral | valuation · target upside +20.9% | **Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr. ## Munger Lens - **Verdict:** Fairly Valued - **Financial Health:** Moderate - **Margin of Safety:** Moderate - **Interest Coverage:** Adequate - **ROIC vs WACC:** Healthy **Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget. ## Technical Levels - **RSI(14):** 43.1 — momentum zayıf — oversold yakınında değil ama alıcı baskısı az - **50d MA:** $90 — hisse %3.4 altında — kısa vadeli direnç - **200d MA:** $99 — hisse %12.2 altında — uzun vadeli baskı - **Volume (10d):** -13% ## Past Performance (4 Quarters) | Quarter | EPS Actual | EPS Estimate | Result | Reaction | |---|---|---|---|---| | Q2 FY25 | $0.93 | $0.88 | BEAT | +1.9% | | Q3 FY25 | $0.99 | $0.95 | BEAT | -3.0% | | Q4 FY25 | $1.04 | $0.98 | BEAT | -6.2% | | Q1 FY26 | $1.07 | $1.02 | +4.9% EPS | +4.5% | Q1 (April 29, 2026): EPS $1.07 vs $1.02 est^[FMP], +4.9% beat. D+1 movement: +4.5%^{[FMP D+1]}. Decline despite beat — market reacted to guidance, not numbers. ## 3 Scenarios ### Scenario A · Beat **Q4 EPS > $1.00 + CapEx discipline** Threshold: EPS > $1.00^{[FMP est]}. Target: Break above median target $105^{[FMP target]}; high target $113^[FMP] upper bound. ### Scenario B · In-Line **EPS ≈ $1.00 + CapEx < $12.0M** Threshold: EPS ≈ $1.00^{[FMP est]}, Q4 CapEx < $12.0M^[FMP]. Target: Consolidation in the band between current $87^[FMP] and median $105^[FMP]. ### Scenario C · Miss **EPS < $0.97 or CapEx ≥ $12.0M** Threshold: EPS < $0.97^{[FMP est×0.97]}. Target: Current $87 below SMA200 $99^[FMP], if rejection continues, $84^[derived] support activates. ## Risk Notes ### Primary segment below threshold Q1: EPS $1.07 vs $1.02 beat^[FMP], stock +4.5% D+1^[FMP]. ### Backlog concentration No RPO/backlog concentration disclosed in Q1 earnings call. ### Insider trading Form 4 data is marked in the table — this page does not generate assumptions for this stock. | Executive | Action | Amount | Date | |---|---|---|---| **Net:** — (0 transactions · 0 sells · 0 buys) · Q1 FY26 ### CapEx shock Q1 CapEx $12.0M^{[FMP cashflow]}. Q1 op margin 23.8%^{[FMP op margin]} — this level in Q4 is sensitive to CapEx revision risk. ## Wall Street Consensus - **Median target:** $105 (+20.9% upside vs current $87) - **High / Low:** $113 / $102 - **Buy / Hold / Sell:** 12 / 8 / 0 - **Analyst count:** 4 (last quarter), 26 all-time ## Additional Transcript Insights ### 1. fy26_eps_guidance **Claim:** Veralto raised its full year adjusted earnings per share guidance to a range of $4.20 to $4.28 per share, reflecting its strong first quarter and momentum throughout the year. **Evidence (transcript):** "Reflecting this momentum and our strong first quarter, we raised our full year adjusted earnings per share guidance to a range of $4.20 to $4.28 per share." **Numbers:** $4.20, $4.28 ### 2. strategic_acquisitions **Claim:** Veralto invested approximately $1 billion across 2 strategic acquisitions: In-Situ in our Water Quality segment and GlobalVision in our PQI segment, and also made opportunistic share repurchases. **Evidence (transcript):** "Thus far this year, we have invested approximately $1 billion across 2 strategic acquisitions: In-Situ in our Water Quality segment and GlobalVision in our PQI segment, and also made opportunistic share repurchases." **Numbers:** $1 billion, 2 ### 3. cost_optimization_program **Claim:** Veralto initiated a new cost optimization program designed to streamline our business and enhance operating efficiency. **Evidence (transcript):** "Additionally, we initiated a new cost optimization program designed to streamline our business and enhance operating efficiency." **Numbers:** — ### 4. water_quality_demand **Claim:** Veralto sees strong and stable demand across both its muni and industrial markets, with incrementally stronger growth in muni wastewater due to recycle, reclaim and reuse secular drivers. **Evidence (transcript):** "Yes, we see strong and stable demand across both our muni and industrial markets. To your point, the Veralto products and services really sit within customer operations where the cost of failure is high for them, right? And using our equipment is part and parcel to ensuring public safety, public health and so on." **Numbers:** — ### 5. pqi_packaging_color_decline **Claim:** In PQI, packaging and color sales were down high single digits in Q1, primarily due to nonrecurring revenue, including sales of color testing and packaging inspection equipment, focused in a few discrete industrial end markets, such as automotive, textiles, building materials. **Evidence (transcript):** "When you look at Q1 here relative to packaging and color, as you noted, we do see sales down high single digits here, primarily due to the nonrecurring revenue, including sales of color testing and packaging inspection equipment. But this was really focused in a few discrete industrial end markets, so automotive, textiles, building materials, driven by housing market and so on." **Numbers:** — ### 6. cost_optimization_timeline **Claim:** Approximately 50% of the run rate savings from Veralto's cost optimization program are expected in 2027, with the full run rate in 2028; no benefit has been baked into guidance for 2026. **Evidence (transcript):** "You should expect roughly 50% of the run rate savings in '27 and full run rate in 2028. That's how you can model the savings." **Numbers:** 50%, 27, 2028 --- *Data source: FMP (live query, 2026-05-09), Q1 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*